Updates
Stay informed on recent developments in the world of biomarkers for bladder cancer surveillance
Webinar on Bladder EpiCheck®, for NMIBC monitoring
On Tuesday October 6th 2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...
Interested in the place of urinary markers in NMIBC follow-up?
Watch a webinar by Prof. Fred Witjes On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes,...
Methylation-based assay & TPS reporting of urine cytology
Reviewed by Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, the Netherlands) Data from a recent study support the use of a urinary methylation-based assay, i.e. Bladder EpiCheck®, to accurately identify recurrence in patients with high-grade...
Urinary markers in low-grade NMIBC: Ready to stop cystoscopies?
Reviewed by Morgan Rouprêt (Pitié-Salpêtrière Hospital – AP-HP Sorbonne University, Paris, France) Prof. Fred Witjes (Radboud UMC, Nijmegen, The Netherlands) recently discussed the opportunity to use urinary markers to reduce the number of cystoscopies in...
Invitation to webinar on NMIBC follow-up
Nucleix, Israel and Oncotest-Rhenium, Israel are pleased to invite you to the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”, led by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands. The webinar...
BCaMonitor.org is now live!
We are excited to announce that our web platform is now available. We aim to share information on bladder cancer biomarker tests, how they can provide accurate detection of recurrence and decrease patient burden. Check out our: informative slide resource on biomarker...